Position in GSK
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$17,180,205
-$33,604,245 QoQ
Shares Held
311,292
-69.9% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $598,181,374 across 8 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
|
2,217,376 | $280,143,283 | |
| 2 | NVO |
Novo Nordisk A S
|
3,032,421 | $145,374,262 | |
| 3 | NVS |
Novartis AG
|
788,033 | $123,500,531 | |
| 4 | LLY |
ELI LILLY & Co
|
26,091 | $31,294,330 | |
| 5 | BIIB |
Biogen Inc.
|
77,744 | $16,797,368 | |
| 6 | AMRN |
Amarin Corp Plc\Uk
|
48,369 | $771,001 | |
| 7 | SCLX |
Scilex Holding Co
|
33,064 | $257,899 | |
| 8 | NSRX |
Nasus Pharma Ltd
|
12,200 | $42,700 |
All Filings in GSK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17,180,205 | 311,292 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $50,784,450 | 1,035,572 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $85,800,051 | 1,987,953 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $86,432,755 | 2,250,853 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $76,788,607 | 1,982,153 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $93,180,627 | 2,755,193 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $95,474,953 | 2,335,493 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $90,397,730 | 2,347,993 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $76,882,757 | 1,793,393 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $102,478,052 | 2,765,193 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $105,559,746 | 2,911,993 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $107,708,855 | 3,022,134 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $150,483,866 | 4,229,451 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $222,687,486 | 6,337,151 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $275,289,897 | 9,354,057 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $426,059,366 | 9,979,321 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $427,745,788 | 10,011,921 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $442,282,997 | 10,225,421 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $352,818,305 | 9,414,421 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $353,894,023 | 9,061,321 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $306,747,376 | 8,763,021 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $515,104,677 | 14,271,421 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $676,681,555 | 18,329,654 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $822,190,566 | 20,551,254 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $857,578,998 | 23,076,454 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||